Hyperuricemia as a marker for progression of immunoglobulin A nephropathy

Kidney Research and Clinical Practice

Volumn 31, Issue 3, 2012, Pages 186-191

  Kim, Su Ji ^a   Kim, Jung Hoon ^a   Gil, Hyo Wook ^a   Yang, Jong Oh ^a   Lee, Eun Young ^a   Hong, Sae Yong ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Hyperuricemia; Immunoglobulin A nephropathy

Indexed keywords

CREATININE; IMMUNOGLOBULIN A; URIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SURVIVAL RATE; URIC ACID BLOOD LEVEL;

EID: 84879194366     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2012.07.003     Document Type: Article

References (24)

1. B.A. Julian, F.B. Waldo, A. Rifai, and J. Mestecky IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 84 1988 129 132
2. G. D'Amico Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome Semin Nephrol 24 2004 179 196
3. G. D'Amico Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors Am J Kidney Dis 36 2000 227 237
4. J. Syrjänen, J. Mustonen, and A. Pasternack Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy Nephrol Dial Transplant 15 2000 34 42
5. I. Ohno, T. Hosoya, H. Gomi, K. Ichida, H. Okabe, and M. Hikita Serum uric acid and renal prognosis in patients with IgA nephropathy Nephron 87 2001 333 339
6. A.A. Ejaz, W. Mu, D.H. Kang, C. Roncal, Y.Y. Sautin, G. Henderson, I. Tabah-Fisch, B. Keller, T.M. Beaver, T. Nakagawa, and R.J. Johnson Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2 2007 16 21
7. D.H. Kang, T. Nakagawa, L. Feng, S. Watanabe, L. Han, M. Mazzali, L. Truong, R. Harris, and R.J. Johnson A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2002 2888 2897
8. D.I. Feig, T. Nakagawa, S.A. Karumanchi, W.J. Oliver, D.H. Kang, J. Finch, and R.J. Johnson Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension Kidney Int 66 2004 281 287
9. R.J. Johnson, S.D. Kivlighn, S.G. Kim, S. Suga, and A.B. Fogo Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease Am J Kidney Dis 33 1999 225 234
10. R.J. Johnson, D.H. Kang, D. Feig, S. Kivlighn, J. Kanellis, S. Watanabe, K.R. Tuttle, B. Rodriguez-Iturbe, J. Herrera-Acosta, and M. Mazzali Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41 2003 1183 1190
11. S.M. Lee, V.M. Rao, W.A. Franklin, M.S. Schiffer, A.J. Aronson, B.H. Spargo, and A.I. Katz IgA nephropathy: morphologic predictors of progressive renal disease Hum Pathol 13 1982 314 322
12. J.V. Selby, G.D. Friedman, and C.P. Quesenberry Jr Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries Am J Epidemiol 131 1990 1017 1027
13. F. Jossa, E. Farinaro, S. Panico, V. Krogh, E. Celentano, R. Galasso, M. Mancini, and M. Trevisan Serum uric acid and hypertension: the Olivetti heart study J Hum Hypertens 8 1994 677 681
14. J. Fang, and M.H. Alderman Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey JAMA 283 2000 2404 2410
15. K. Iseki, Y. Ikemiya, T. Inoue, C. Iseki, K. Kinjo, and S. Takishita Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort Am J Kidney Dis 44 2004 642 650
16. R.J. Johnson, and B.A. Rideout Uric acid and diet - Insights into the epidemic of cardiovascular disease N Engl J Med 350 2004 1071 1073
17. Y.P. Siu, K.T. Leung, M.K. Tong, and T.H. Kwan Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis 47 2006 51 59
18. N.D. Vaziri, R.W. Freel, and M. Hatch Effect of chronic experimental renal insufficiency on urate metabolism J Am Soc Nephrol 6 1995 1313 1317
19. M.G. Radford Jr, J.V. Donadio Jr, E.J. Bergstralh, and J.P. Grande Predicting renal outcome in IgA nephropathy J Am Soc Nephrol 8 1997 199 207
20. L. Frimat, S. Briancon, D. Hestin, B. Aymard, E. Renoult, T.C. Huu, and M. Kessler IgA nephropathy: Prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est Nephrol Dial Transplant 12 1997 2569 2575
21. J.V. Donadio, E.J. Bergstarlh, J.P. Grande, and D.M. Rademcher Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy Nephrol Dial Transplant 17 2002 1197 1203
22. Y. Sasatomi, M. Tada, N. Uesugi, S. Hisano, and S. Takebayashi Obesity associated with hypertension or hyperlipidemia accelerated renal damage Pathobiology 69 2001 113 118
23. M. Tozawa, K. Iseki, C. Iseki, S. Oshiro, Y. Ikemiya, and S. Takishita Influence of smoking and obesity on the development of proteinuria Kidney Int 62 2002 956 962
24. J. Myllymäki, T. Honkanen, J. Syrjänen, H. Helin, I. Rantala, A. Pasternack, and J. Mustonen Uric acid correlates with the severity of histopathological parameters in IgA nephropathy Nephrol Dial Transplant 20 2005 89 95